Rmb Capital Management, LLC Sage Therapeutics, Inc. Transaction History

Rmb Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$60.18 - $154.77 $378,472 - $973,348	-6,289 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$157.85 - $183.09 $991,771 - $1.15 Million	-6,283 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $492,565 - $902,366	-5,514 Reduced 46.74%	6,283 $999,000
Q4 2018 Feb 13, 2019	SELL	$81.94 - $139.71 $40,642 - $69,296	-496 Reduced 4.03%	11,797 $1.13 Million
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $157,445 - $192,705	-1,140 Reduced 8.49%	12,293 $1.74 Million
Q2 2018 Aug 13, 2018	SELL	$140.36 - $175.76 $920,059 - $1.15 Million	-6,555 Reduced 32.79%	13,433 $0
Q1 2018 May 14, 2018	BUY	$152.15 - $192.33 $3.04 Million - $3.84 Million	19,988 New	19,988 $3.22 Million
Q4 2017 Feb 14, 2018	SELL	$60.72 - $167.34 $2.5 Million - $6.9 Million	-41,250 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	41,250	41,250 $3.29 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $303M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rmb Capital Management, LLC with notifications on news.